Publisher's Synopsis
The biological analysis laboratory plays an important role in the diagnosis of patients with haemostasis disorders. It provides the basis for monitoring antithrombotic therapies, both for patients treated with heparin and those on oral anticoagulants. It is therefore important to put in place the necessary control tools to ensure quality analysis results as quickly as possible.The aim of this paper is to set out documented approaches to quality control in the haemostasis analysis phase, in order to provide confirmation and permanent proof of the validity of results delivered at a reasonable cost, and to enable rapid and efficient detection of anomalies, without unnecessary alarms.
